Health Atlas
Menu
Evidence-led reference

Biological age: what does an aging test actually measure?

If a test says you are five years younger, did your health improve?

8 sources · Latest source check 2026-10-15 UTC
On this page

Biological age is a modeled summary of age-related features, not a second birth date. An epigenetic clock combines DNA methylation measurements: chemical marks at selected DNA sites. Different algorithms are trained to estimate chronological age, clinical risk or pace of aging. A result depends on the clock’s target, specimen and reference population.[1]

What does this actually mean?

The meaning

Chronological age is the time since birth. A biological-age estimate summarizes selected measurements using a statistical model. NIH describes research linking some DNA-methylation-based estimates with later health outcomes in older adults. These are promising research associations, not a second birth certificate or a direct measurement of every organ’s remaining lifespan.[8]

One family of clocks

Epigenetic clocks use DNA methylation patterns at selected sites. Horvath’s original model combined these measurements to estimate age across many tissues and cell types.[1]

The sample belongs to the result

A blood-based age model was trained using blood samples and particular laboratory data. A saliva test or another algorithm needs its own relevant validation. Shared units such as years do not establish interchangeable measurements. Ask which specimen, model version and comparison population produced the result before comparing it with another company’s number or a previous test.[2]

Different targets produce different meanings

GrimAge was developed using methylation-based surrogates for selected proteins and smoking history, then related to mortality risk. Its age-like unit is a statistical presentation, not a personal death date. A clock can capture known risk patterns as well as other information. Predictive association therefore does not identify a single aging mechanism that can necessarily be reversed.[4]

Repeatability comes before interpreting change

Technical replicate results can differ. Higgins-Chen and colleagues developed a method to improve clock reliability, emphasizing that measurement noise matters when interpreting a small change over time.[6]

Changing a marker is not extending life

DO-HEALTH’s post hoc analysis examined methylation clocks in older trial participants. Effects were modest and differed between clocks. This supports further research, but does not establish that a younger retest adds equivalent life-years or proves a supplement helped its purchaser.[7]

What to check

PhenoAge illustrates why the training target matters: it was informed by clinical risk features rather than chronological age alone. Ask whether the offered test predicts age, health risk or change, how repeatable it is, and whether acting on it improves outcomes. Those are separate validation questions. Prediction and a useful treatment decision are separate tests of a model.[3]

Age estimation and health estimation are different targets

Horvath’s 2013 multi-tissue clock predicted age across many tissues and cell types. Reconstructing chronological age answers a different question from complete health assessment. Age acceleration usually compares a clock estimate with calendar age, sometimes after statistical adjustment; the difference is model-dependent. Selected methylation sites do not directly reveal every organ’s age, and a blood result cannot supply an exact age for the heart or brain.[1]

Clock targets and units should be named before reading the score
Method or termWhat it describesMain limitation
Age-prediction clockMethylation estimate of chronological age, yearsAccuracy in age prediction is not complete health assessment[1]
Risk-informed clockPattern trained around clinical or mortality featuresPrediction does not prove reversibility[3]
Pace-of-aging modelEstimated rate relative to a reference normA rate is not an age in years[5]

Samples, units and populations affect comparison

Hannum and colleagues developed an earlier blood-based methylation model using adults across a broad age span. Specimen, age range and training data therefore belong in the test description. A blood-derived age and a commercial saliva score are not interchangeable just because both use years. Methylation proportions summarize a population of cells; changing cell composition and preprocessing can affect interpretation.[2]

Pace is a rate, not an age gap

DunedinPACE was trained on longitudinal physiological changes in the Dunedin cohort and a methylation algorithm. Its rate is scaled around one biological year per calendar year in its reference framework. This is not a statement of how many years older or younger a person is. The original work evaluated reliability and associations in additional datasets; transfer to another specimen, population or commercial implementation still requires relevant validation.[5]

Evidence & uncertainty

Research biomarkers can be informative without being validated personal treatment targets. Repeatable measurement, association with disease, response to an intervention and proof that improving the number improves health are separate steps.[6]

Selected-source overview · Independent review pending

Published questions

Is biological age my body’s true age?

Selected-source overview · Independent review pending. Read the evidence context.

No single agreed measurement defines it. A clock estimates its trained target from selected features; chronological age prediction and health-risk prediction are different tasks.[1]

Evidence behind this answer
  • DNA methylation age of human tissues and cell types

    original research or professional guidance · 2013
    Original official page or original full-text article: relevant passages inspected; no independent expert review. · Original article; multi-tissue training, validation, target and CpG framework

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can blood and saliva scores be compared directly?

Selected-source overview · Independent review pending. Read the evidence context.

Only with relevant validation. The sample, model, cell mixture and processing influence the result; the shared unit “years” does not establish interchangeability.[2]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does an older PhenoAge diagnose a disease?

Selected-source overview · Independent review pending. Read the evidence context.

No. The original study evaluated statistical associations and prediction in cohorts. A modeled age is not a disease-specific diagnostic result.[3]

Evidence behind this answer
  • An epigenetic biomarker of aging for lifespan and healthspan

    original research or professional guidance · 2018
    Original official page or original full-text article: relevant passages inspected; no independent expert review. · Original introduction, two-step phenotypic target and cohort outcome associations

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can GrimAge tell me when I will die?

Selected-source overview · Independent review pending. Read the evidence context.

No. Cohort-level time-to-event prediction does not give a personal death date, and methylation surrogates are not direct measurements of every included exposure.[4]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a pace score of 1.1 mean I am 1.1 years older?

Selected-source overview · Independent review pending. Read the evidence context.

No. Pace describes an estimated rate in a reference framework. It is different from an age estimate or an age-minus-calendar-age difference.[5]

Evidence behind this answer
  • DunedinPACE, a DNA methylation biomarker of the pace of aging

    original research or professional guidance · 2022
    Original full-text article relevant methods/results retrieved through PMC (PMC8853656). Direct eLife access was blocked. Complete supplementary files were not independently appraised. · Indexed original methods/results; longitudinal training, reliability and pace units

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a younger retest prove my supplement worked?

Selected-source overview · Independent review pending. Read the evidence context.

No. Technical variability, assay changes and ordinary variation can affect retests. Causal inference also needs an appropriate comparison and meaningful outcomes.[6]

Evidence behind this answer
  • A computational solution for bolstering reliability of epigenetic clocks

    original research or professional guidance · 2022
    Original indexed abstract and methods snippets inspected; direct publisher and PMC opens failed. No complete tables or supplementary appraisal claimed. · Original indexed abstract: technical replicates and principal-component reliability

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a trial changing an aging clock prove that consumers live longer?

Selected-source overview · Independent review pending. Read the evidence context.

No. DO-HEALTH’s post hoc analysis measured modest, clock-dependent changes in selected older participants. A biomarker response does not by itself establish a lifespan benefit.[7]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

If a test says you are five years younger, did your health improve?

Selected-source overview · Independent review pending. Read the evidence context.

Not necessarily. A younger model estimate can change without demonstrating better health or longer life. DO-HEALTH found clock-dependent responses, not added life-years for years shifted.[7]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a repeatable aging-clock result prove that using the test improves health?

Selected-source overview · Independent review pending. Read the evidence context.

No. Repeatability concerns whether measurements agree under repeated testing. It does not by itself demonstrate that a treatment guided by the result improves health outcomes; that requires a different kind of evaluation.[6]

Evidence behind this answer
  • A computational solution for bolstering reliability of epigenetic clocks

    original research or professional guidance · 2022
    Original indexed abstract and methods snippets inspected; direct publisher and PMC opens failed. No complete tables or supplementary appraisal claimed. · Original indexed abstract: technical replicates and principal-component reliability

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

PhenoAge combines clinical and molecular information

Levine’s DNAm PhenoAge was informed by composite clinical phenotypic age rather than chronological age alone. It showed associations with mortality and several health-related outcomes in studied cohorts. These support a different prediction target from a pure age-estimation clock. They do not diagnose disease in an individual or establish that repeated testing improves health. Predicting a pattern is not the same as locating a reversible aging mechanism.[3]

GrimAge predicts risk using surrogate features

Lu’s GrimAge combines methylation-based surrogates for plasma proteins and smoking history with other information and was evaluated against outcomes including time to death. A surrogate statistically estimates another feature rather than directly measuring it. Cohort prediction does not supply a purchaser’s date of death. A clock may predict risk partly by capturing known harmful exposures, rather than measuring one universal aging process.[4]

Small changes can reflect technical noise

Higgins-Chen and colleagues found substantial differences between technical replicates for several established clocks; their principal-component approach improved reliability. Collection, assay batches, preprocessing and clock versions can produce changes independent of durable health improvement. Better repeatability does not automatically establish clinical utility. An uncontrolled before-and-after experiment also mixes intervention effects with variation and regression to the mean. Request repeatability evidence for the offered test, not a generic laboratory-quality claim.[6]

Different clocks can disagree about the same intervention

A post hoc DO-HEALTH analysis evaluated four methylation measures in 777 older participants over three years. Effects of omega-3, vitamin D and exercise differed across clocks and combinations; reported clock effects were small. Researchers interpret these changes as encouraging evidence of intervention responsiveness, while clinical meaning and generalizability remain unresolved. A statistically detectable clock change is not proof of added lifespan, and a selected older study population does not establish the same effect in younger consumers. This is measurement evidence, not a supplement regimen or exercise prescription.[7]

References

  1. DNA methylation age of human tissues and cell types

    Original research or professional guidance

    Horvath S · Content/publication date: 2013
    Accessed: 2026-10-13 UTC · Original official page or original full-text article: relevant passages inspected; no independent expert review.
    Cited sections: Original article; multi-tissue training, validation, target and CpG framework

    Publication date is distinguished from this retrieval date.

  2. Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates

    Original research or professional guidance

    Hannum G and colleagues · Content/publication date: 2013
    Accessed: 2026-10-13 UTC · Original official page or original full-text article: relevant passages inspected; no independent expert review.
    Cited sections: Author-institution PDF; whole-blood cohorts, methylation fractions and model target

    Publication date is distinguished from this retrieval date.

  3. An epigenetic biomarker of aging for lifespan and healthspan

    Original research or professional guidance

    Levine ME and colleagues · Content/publication date: 2018
    Accessed: 2026-10-13 UTC · Original official page or original full-text article: relevant passages inspected; no independent expert review.
    Cited sections: Original introduction, two-step phenotypic target and cohort outcome associations

    Publication date is distinguished from this retrieval date.

  4. DNA methylation GrimAge strongly predicts lifespan and healthspan

    Original research or professional guidance

    Lu AT and colleagues · Content/publication date: 2019
    Accessed: 2026-10-13 UTC · Original official page or original full-text article: relevant passages inspected; no independent expert review.
    Cited sections: Original article: protein and smoking surrogates, cohort prediction and interpretation

    Publication date is distinguished from this retrieval date.

  5. DunedinPACE, a DNA methylation biomarker of the pace of aging

    Original research or professional guidance

    Belsky DW and colleagues · Content/publication date: 2022
    Accessed: 2026-10-13 UTC · Original full-text article relevant methods/results retrieved through PMC (PMC8853656). Direct eLife access was blocked. Complete supplementary files were not independently appraised.
    Cited sections: Indexed original methods/results; longitudinal training, reliability and pace units

    Publication date is distinguished from this retrieval date.

  6. A computational solution for bolstering reliability of epigenetic clocks

    Original research or professional guidance

    Higgins-Chen AT and colleagues · Content/publication date: 2022
    Accessed: 2026-10-13 UTC · Original indexed abstract and methods snippets inspected; direct publisher and PMC opens failed. No complete tables or supplementary appraisal claimed.
    Cited sections: Original indexed abstract: technical replicates and principal-component reliability

    Publication date is distinguished from this retrieval date.

  7. Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks: DO-HEALTH

    Original research or professional guidance

    Bischoff-Ferrari HA and colleagues · Content/publication date: 2025
    Accessed: 2026-10-13 UTC · Original official page or original full-text article: relevant passages inspected; no independent expert review.
    Cited sections: Original post hoc N=777, three-year biomarker analysis; differing clock responses and limitations

    Publication date is distinguished from this retrieval date.

  8. Age estimated by changes to DNA can help predict health outcomes, mortality in older adults

    Original research or professional guidance

    US National Institute on Aging · Content/publication date: 2024
    Accessed: 2026-10-15 UTC · Indexed original NIH summary inspected; direct page open failed, so no complete-page access claimed.
    Cited sections: Indexed original NIH research summary: clock families and older-adult associations

    Population prediction is not clinical utility.

Scope & review

Population
General readers; study populations and intended device uses are specified
Exposure or intervention
Biological age tests: clock families, risk prediction, repeatability and longevity claims
Comparison
Source-specific tests, device methods and usual-care comparisons
Outcomes
Measurement validity, interpretation, practical limits and source-specific health outcomes
Timeframe
Historical and contemporary sources checked 2026-10-13
Jurisdiction
US guidance and explicitly identified international studies; laboratory and device requirements differ

Selected-source educational explanation. Definitions, source findings and editorial interpretation are distinguished; no exhaustive search, independent systematic synthesis or qualified medical review completed.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-13 UTC: Added a selected-source educational explanation in edition 4.1; independent medical review remains pending.
  • 2026-10-15 UTC: Added the plain-English series explanation with definitions, distinctions, practical questions and selected primary sources; qualified review remains pending.

What this article still leaves open

  • Independent medical review and a comprehensive literature synthesis remain unfinished.
  • Individual test interpretation, current brand ranking and personalized treatment decisions are outside this explainer.
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

More in the plain-English series

Keep making sense of it.

Explore Healthy aging explanations See every explanation

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.